a team led by imperial college london has already applied to patent the therapy , which they say could be ready for human trials within three years .
the protein promotes the production of immune cells called cytotoxic t-cells , which have the ability to detect cancerous cells , hunt them down , and destroy them .
the protein promotes the production of immune cells called cytotoxic t-cells , which have the ability to detect cancerous cells , hunt them down , and destroy them .